These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
828 related items for PubMed ID: 21802126
1. Sustained 3-year efficacy of pre- and coseasonal 5-grass-pollen sublingual immunotherapy tablets in patients with grass pollen-induced rhinoconjunctivitis. Didier A, Worm M, Horak F, Sussman G, de Beaumont O, Le Gall M, Melac M, Malling HJ. J Allergy Clin Immunol; 2011 Sep; 128(3):559-66. PubMed ID: 21802126 [Abstract] [Full Text] [Related]
2. Post-treatment efficacy of discontinuous treatment with 300IR 5-grass pollen sublingual tablet in adults with grass pollen-induced allergic rhinoconjunctivitis. Didier A, Malling HJ, Worm M, Horak F, Sussman G, Melac M, Soulié S, Zeldin RK. Clin Exp Allergy; 2013 May; 43(5):568-77. PubMed ID: 23600548 [Abstract] [Full Text] [Related]
3. Sublingual immunotherapy with once-daily grass allergen tablets: a randomized controlled trial in seasonal allergic rhinoconjunctivitis. Durham SR, Yang WH, Pedersen MR, Johansen N, Rak S. J Allergy Clin Immunol; 2006 Apr; 117(4):802-9. PubMed ID: 16630937 [Abstract] [Full Text] [Related]
4. Clinical efficacy of 300IR 5-grass pollen sublingual tablet in a US study: the importance of allergen-specific serum IgE. Cox LS, Casale TB, Nayak AS, Bernstein DI, Creticos PS, Ambroisine L, Melac M, Zeldin RK. J Allergy Clin Immunol; 2012 Dec; 130(6):1327-34.e1. PubMed ID: 23122534 [Abstract] [Full Text] [Related]
5. Comparative effect of pre-coseasonal and continuous grass sublingual immunotherapy in children. Stelmach I, Kaluzińska-Parzyszek I, Jerzynska J, Stelmach P, Stelmach W, Majak P. Allergy; 2012 Mar; 67(3):312-20. PubMed ID: 22142341 [Abstract] [Full Text] [Related]
10. Efficacy of grass pollen sublingual immunotherapy for three consecutive seasons and after cessation of treatment: the ECRIT study. Ott H, Sieber J, Brehler R, Fölster-Holst R, Kapp A, Klimek L, Pfaar O, Merk H. Allergy; 2009 Jan; 64(1):179-86. PubMed ID: 19076534 [Abstract] [Full Text] [Related]
11. A prospective, randomized, double-blind, placebo-controlled multi-centre study on the efficacy and safety of sublingual immunotherapy (SLIT) in children with seasonal allergic rhinoconjunctivitis to grass pollen. Rolinck-Werninghaus C, Wolf H, Liebke C, Baars JC, Lange J, Kopp MV, Hammermann J, Leupold W, Bartels P, Gruebl A, Bauer CP, Schnitker J, Wahn U, Niggemann B. Allergy; 2004 Dec; 59(12):1285-93. PubMed ID: 15507097 [Abstract] [Full Text] [Related]
12. Safety and efficacy in children of an SQ-standardized grass allergen tablet for sublingual immunotherapy. Bufe A, Eberle P, Franke-Beckmann E, Funck J, Kimmig M, Klimek L, Knecht R, Stephan V, Tholstrup B, Weisshaar C, Kaiser F. J Allergy Clin Immunol; 2009 Jan; 123(1):167-173.e7. PubMed ID: 19130937 [Abstract] [Full Text] [Related]
13. Efficacy of sublingual swallow immunotherapy in children with severe grass pollen allergic symptoms: a double-blind placebo-controlled study. Bufe A, Ziegler-Kirbach E, Stoeckmann E, Heidemann P, Gehlhar K, Holland-Letz T, Braun W. Allergy; 2004 May; 59(5):498-504. PubMed ID: 15080830 [Abstract] [Full Text] [Related]
14. Sublingual grass allergen tablet immunotherapy provides sustained clinical benefit with progressive immunologic changes over 2 years. Dahl R, Kapp A, Colombo G, de Monchy JG, Rak S, Emminger W, Riis B, Grønager PM, Durham SR. J Allergy Clin Immunol; 2008 Feb; 121(2):512-518.e2. PubMed ID: 18155284 [Abstract] [Full Text] [Related]
15. Allergy immunotherapy tablet: Grazax® for the treatment of grass pollen allergy. Senna GE, Calderon M, Milani M. Expert Rev Clin Immunol; 2011 Jan; 7(1):21-7. PubMed ID: 21162646 [Abstract] [Full Text] [Related]
17. Efficacy and safety of specific immunotherapy with SQ allergen extract in treatment-resistant seasonal allergic rhinoconjunctivitis. Frew AJ, Powell RJ, Corrigan CJ, Durham SR, UK Immunotherapy Study Group. J Allergy Clin Immunol; 2006 Feb; 117(2):319-25. PubMed ID: 16461133 [Abstract] [Full Text] [Related]
18. Treatment of seasonal allergic rhinoconjunctivitis with a once-daily SQ-standardized grass allergy immunotherapy tablet. Nelson H, Lehmann L, Blaiss MS. Curr Med Res Opin; 2012 Jun; 28(6):1043-51. PubMed ID: 22502864 [Abstract] [Full Text] [Related]
19. Efficacy and safety of sublingual immunotherapy with grass monomeric allergoid: comparison between two different treatment regimens. Quercia O, Bruno ME, Compalati E, Falagiani P, Mistrello G, Stefanini GF. Eur Ann Allergy Clin Immunol; 2011 Dec; 43(6):176-83. PubMed ID: 22360134 [Abstract] [Full Text] [Related]
20. Grass pollen immunotherapy as an effective therapy for childhood seasonal allergic asthma. Roberts G, Hurley C, Turcanu V, Lack G. J Allergy Clin Immunol; 2006 Feb; 117(2):263-8. PubMed ID: 16461125 [Abstract] [Full Text] [Related] Page: [Next] [New Search]